Shenyang Xingqi Pharmaceutical Co. Ltd Financials

Market Capitalization CN¥12.83 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	28.57
Forward PE	12.07
Price to Sales TTM	CN¥6.02
Price to Book MRQ	CN¥7.36
Enterprise to Revenue	5.82
Enterprise to EBITDA	19.26

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	21.09%
Operating Margin	34.59%
Return on Assets TTM	15.54%
Return on Equity TTM	25.82%

Income Statement

Revenue TTM	CN¥2,129,652,224
Revenue per Share TTM	CN¥8.70
Quarterly Revenue Growth	53.20%
Gross Profit TTM	CN¥1,682,340,992
EBITDA	CN¥556,221,465
Net Income to Common TTM	CN¥449,208,128
Diluted EPS TTM	CN¥1.83
Quarterly Earnings Growth YoY	319.90%

Balance Sheet

Total Cash MRQ	CN¥505,157,888
Total Cash per Share MRQ	CN¥2.06
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	11.36
Current Ratio MRQ	2.00
Book Value per Share MRQ	CN¥7.11

Cash Flow

Operating Cash Flow TTM	CN¥524,167,008
Levered Free Cash Flow TTM	CN¥289,230,144

300573 Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	175,249,247
Float Shares	169,867,343
Avg 10 Volume	5,625,309
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	30.92%
% Held by Institutions	11.46%

Stock Price Summary

Beta	0.34
Fifty Two Week Low	CN¥46.34
Fifty Two Week High	CN¥115.47
Fifty Two Week Change	-109.26%
Day 50 MA	CN¥54.17
Day 200 MA	CN¥56.34

Dividends and Splits

Forward Annual Dividend Rate	CN¥1.43
Forward Annual Dividend Yield	2.73%
Trailing Annual Dividend Rate	CN¥1.07
Trailing Annual Dividend Yield	2.05%
Payout Ratio	136.72%
Dividend Date
Ex Dividend Date	2025-05-22
Last Split Factor
Last Split Date	2025-05-22